Systemic administration of human adipose-derived stem cells reverts nociceptive hypersensitivity in an experimental model of neuropathy

Stem Cells and Development

Volumn 22, Issue 8, 2013, Pages 1252-1263

  Sacerdote, Paola ^a   Niada, Stefania ^a,b   Franchi, Silvia ^a   Arrigoni, Elena ^a   Rossi, Alice ^a   Yenagi, Vijay ^a   De Girolamo, Laura ^b   Panerai, Alberto Emilio ^a   Brini, Anna Teresa ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; NITRIC OXIDE SYNTHASE;

ADIPOSE DERIVED STEM CELL; ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CELL CULTURE; CELL THERAPY; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; HYPERALGESIA; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NERVE CELL LESION; NERVOUS SYSTEM INFLAMMATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCIATIC NERVE INJURY; SPINAL CORD;

ADIPOSE TISSUE; ADULT; ADULT STEM CELLS; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERALGESIA; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; NEURALGIA; NITRIC OXIDE SYNTHASE TYPE II; SCIATIC NEUROPATHY; STEM CELL TRANSPLANTATION; TIME FACTORS;

ANIMALIA; MUS;

EID: 84876144833     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0398     Document Type: Article

References (69)

1. Zuk PA, M Zhu, H Mizuno, J Huang, JW Futrell, AJ Katz, P Benhaim, HP Lorenz and MH Hedrick. (2001). Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 7:211-228.
2. Guilak F, HA Awad, B Fermor, HA Leddy and JM Gimble. (2004). Adipose-derived adult stem cells for cartilage tissue engineering. Biorheology 41:389-399.
3. Conforti E, E Arrigoni, M Piccoli, S Lopa, L de Girolamo, A Ibatici, A Di Matteo, G Tettamanti, AT Brini and L Anastasia. (2011). Reversine increases multipotent human mesenchymal cells differentiation potential. J Biol Regul Homeost Agents 25:S25- S33.
4. Ashjian PH, AS Elbarbary, B Edmonds, D DeUgarte, M Zhu, PA Zuk, HP Lorenz, P Benhaim and MH Hedrick. (2003). In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg 111:1922-1931.
5. Safford KM, SD Safford, JM Gimble, AK Shetty and HE Rice. (2004). Characterization of neuronal/glial differentiation of murine adipose-derived adult stromal cells. Exp Neurol 187:319-328.
6. Choi J, S Kim, J Jung, Y Lim, K Kang, S Park and S Kang. (2011). Wnt5a-mediating neurogenesis of human adipose tissue-derived stem cells in a 3D microfluidic cell culture system. Biomaterials 32:7013-7022.
7. de Girolamo L, S Lopa, E Arrigoni, MF Sartori, FW Baruffaldi Preis and AT Brini. (2009). Human adipose-derived stem cells isolated from young and elderly women: Their differentiation potential and scaffold interaction during in vitro osteoblastic differentiation. Cytotherapy 11:793-803.
8. Quirici N, C Scavullo, L de Girolamo, S Lopa, E Arrigoni, GL Deliliers and AT Brini. (2010). Anti-L-NGFR and -CD34 monoclonal antibodies identify multipotent mesenchymal stem cells in human adipose tissue. Stem Cells Dev 19: 915-925.
9. Yoo KH, IK Jang, MW Lee, HE Kim, MS Yang, Y Eom, JE Lee, YJ Kim, SK Yang, et al. (2009). Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 259:150-156.
10. Nasef A, C Mazurier, S Bouchet, S Francois, A Chapel, D Thierry, NC Gorin and L Fouillard. (2008). Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. Cell Immunol 253:16-22.
11. Najar M, G Raicevic, HI Boufker, H Fayyad-Kazan, C De Bruyn, N Meuleman, D Bron, M Toungouz and L Lagneaux. (2010). Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. Tissue Eng Part A 16:3537-3546.
12. Gonzalez-Rey E, MA Gonzalez, N Varela, F O'Valle, P Hernandez-Cortes, L Rico, D Buscher and M Delgado. (2010). Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 69:241-248.
13. Tholpady SS, RC Ogle and AJ Katz. (2009). Adipose stem cells and solid organ transplantation. Curr Opin Organ Transplant 14:51-55.
14. Constantin G, S Marconi, B Rossi, S Angiari, L Calderan, E Anghileri, B Gini, SD Bach, M Martinello, et al. (2009). Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 27:2624-2635.
15. Choi EW, IS Shin, SY Park, JH Park, JS Kim, EJ Yoon, SK Kang, JC Ra and SH Hong. (2012). Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. Arthritis Rheum 64:243-253.
16. Shibata T, K Naruse, H Kamiya, M Kozakae, M Kondo, Y Yasuda, N Nakamura, K Ota, T Tosaki, et al. (2008). Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats. Diabetes 57:3099-3107.
17. Lunde K, S Solheim, S Aakhus, H Arnesen, M Abdelnoor, T Egeland, K Endresen, A Ilebekk, A Mangschau, et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355:1199-1209.
18. Bernardo ME, N Zaffaroni, F Novara, AM Cometa, MA Avanzini, A Moretta, D Montagna, R Maccario, R Villa, et al. (2007). Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67:9142-9149.
19. Ra JC, IS Shin, SH Kim, SK Kang, BC Kang, HY Lee, YJ Kim, JY Jo, EJ Yoon, HJ Choi and E Kwon. (2011). Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 20:1297-1308.
20. MacIsaac ZM, H Shang, H Agrawal, N Yang, A Parker and AJ Katz. (2012). Long-term in-vivo tumorigenic assessment of human culture-expanded adipose stromal/stem cells. Exp Cell Res 318:416-423.
21. Treede RD, TS Jensen, JN Campbell, G Cruccu, JO Dostrovsky, JW Griffin, P Hansson, R Hughes, T Nurmikko and J Serra. (2008). Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 70:1630-1635.
22. Martucci C, AE Trovato, B Costa, E Borsani, S Franchi, V Magnaghi, AE Panerai, LF Rodella, AE Valsecchi, P Sacerdote and M Colleoni. (2008). The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1 beta, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice. Pain 137:81-95.
23. Valsecchi AE, S Franchi, AE Panerai, P Sacerdote, AE Trovato and M Colleoni. (2008). Genistein, a natural phytoestrogen from soy, relieves neuropathic pain following chronic constriction sciatic nerve injury in mice: Anti-inflammatory and antioxidant activity. J Neurochem 107:230-240.
24. Franchi S, E Giannini, D Lattuada, R Lattanzi, H Tian, P Melchiorri, L Negri, AE Panerai and P Sacerdote. (2008). The prokineticin receptor agonist Bv8 decreases IL-10 and IL-4 production in mice splenocytes by activating prokineticin receptor-1. BMC Immunol 9:60.
25. Musolino PL, MF Coronel, T Hokfelt and MJ Villar. (2007). Bone marrow stromal cells induce changes in pain behavior after sciatic nerve constriction. Neurosci Lett 418:97-101.
26. Siniscalco D, C Giordano, U Galderisi, L Luongo, N Alessio, G Di Bernardo, V de Novellis, F Rossi and S Maione. (2010). Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice. Cell Mol Life Sci 67:655-669.
27. Franchi S, AE Valsecchi, E Borsani, P Procacci, D Ferrari, C Zaffa, P Sartori, LF Rodella, A Vescovi, et al. (2012). Intravenous neural stem cells abolish nociceptive hypersensitivity and trigger nerve regeneration in experimental neuropathy. Pain 153:850-861.
28. Sommer C and M Kress. (2004). Recent findings on how proinflammatory cytokines cause pain: Peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 361:184-187.
29. Achille V, M Mantelli, G Arrigo, F Novara, MA Avanzini, ME Bernardo, O Zuffardi, G Barosi, M Zecca and R Maccario. (2011). Cell-cycle phases and genetic profile of bone marrow-derived mesenchymal stromal cells expanded in vitro from healthy donors. J Cell Biochem 112:1817-1821.
30. Gang EJ, JA Jeong, SH Hong, SH Hwang, SW Kim, IH Yang, C Ahn, H Han and H Kim. (2004). Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 22:617-624.
31. Konno M, TS Hamazaki, S Fukuda, M Tokuhara, H Uchiyama, H Okazawa, H Okochi and M Asashima. (2010). Efficiently differentiating vascular endothelial cells from adipose tissue-derived mesenchymal stem cells in serumfree culture. Biochem Biophys Res Commun 400:461-465.
32. Bodo M, C Lilli, C Bellucci, P Carinci, M Calvitti, F Pezzetti, G Stabellini, S Bellocchio, C Balducci, F Carinci and T Baroni. (2002). Basic fibroblast growth factor autocrine loop controls human osteosarcoma phenotyping and differentiation. Mol Med 8:393-404.
33. Tullberg-Reinert H and G Jundt. (1999). In situ measurement of collagen synthesis by human bone cells with a sirius redbased colorimetric microassay: Effects of transforming growth factor beta2 and ascorbic acid 2-phosphate. Histochem Cell Biol 112:271-276.
34. Guilak F, KE Lott, HA Awad, Q Cao, KC Hicok, B Fermor and JM Gimble. (2006). Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol 206:229-237.
35. Zimmermann M. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.
36. Bennett GJ and YK Xie. (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87-107.
37. Hargreaves K, R Dubner, F Brown, C Flores and J Joris. (1988). A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
38. Valsecchi AE, S Franchi, AE Panerai, A Rossi, P Sacerdote and M Colleoni. (2011). The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model. Eur J Pharmacol 650:694-702.
39. Caplan AI and D Correa. (2011). The MSC: An injury drugstore. Cell Stem Cell 9:11-15.
40. Keating A. (2012). Mesenchymal stromal cells: New directions. Cell Stem Cell 10:709-716.
41. Wislet-Gendebien S, F Wautier, P Leprince and B Rogister. (2005). Astrocytic and neuronal fate of mesenchymal stem cells expressing nestin. Brain Res Bull 68:95-102.
42. Mareschi K, M Novara, D Rustichelli, I Ferrero, D Guido, E Carbone, E Medico, E Madon, A Vercelli and F Fagioli. (2006). Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K+ channel types. Exp Hematol 34:1563-1572.
43. Uccelli A, F Benvenuto, A Laroni and D Giunti. (2011). Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol 24:59-64.
44. O'Connor AB and RH Dworkin. (2009). Treatment of neuropathic pain: An overview of recent guidelines. Am J Med 122:S22- S32.
45. Scholz J and CJ Woolf. (2007). The neuropathic pain triad: Neurons, immune cells and glia. Nat Neurosci 10:1361-1368.
46. Vallejo R, DM Tilley, L Vogel and R Benyamin. (2010). The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract 10:167-184.
47. Siniscalco D, C Giordano, F Rossi, S Maione and V de Novellis. (2011). Role of neurotrophins in neuropathic pain. Curr Neuropharmacol 9:523-529.
48. Iyer SS and M Rojas. (2008). Anti-inflammatory effects of mesenchymal stem cells: Novel concept for future therapies. Expert Opin Biol Ther 8:569-581.
49. Jones BJ and SJ McTaggart. (2008). Immunosuppression by mesenchymal stromal cells: From culture to clinic. Exp Hematol 36:733-741.
50. Le Blanc K and M Pittenger. (2005). Mesenchymal stem cells: Progress toward promise. Cytotherapy 7:36-45.
51. Beggs KJ, A Lyubimov, JN Borneman, A Bartholomew, A Moseley, R Dodds, MP Archambault, AK Smith and KR McIntosh. (2006). Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplant 15:711-721.
52. Marconi S, G Castiglione, E Turano, G Bissolotti, S Angiari, A Farinazzo, G Constantin, G Bedogni, A Bedogni and B Bonetti. (2012). Human adipose-derived mesenchymal stem cells systemically injected promote peripheral nerve regeneration in the mouse model of sciatic crush. Tissue Eng Part A 18:1264-1272.
53. Siniscalco D, C Giordano, U Galderisi, L Luongo, V de Novellis, F Rossi and S Maione. (2011). Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice. Front Integr Neurosci 5:79.
54. Gimble JM, AJ Katz and BA Bunnell. (2007). Adipose-derived stem cells for regenerative medicine. Circ Res 100:1249-1260.
55. Zhuo M. (2007). Neuronal mechanism for neuropathic pain. Mol Pain 3:14.
56. Colleoni M and P Sacerdote. (2010). Murine models of human neuropathic pain. Biochim Biophys Acta 1802: 924-933.
57. Wilson SM, MS Goldwasser, SG Clark, E Monaco, M Bionaz, WL Hurley, S Rodriguez-Zas, L Feng, Z Dymon and MB Wheeler. (2012). Adipose-derived mesenchymal stem cells enhance healing of mandibular defects in the ramus of swine. J Oral Maxillofac Surg 70:e193- e203.
58. Guo W, H Wang, S Zou, M Gu, M Watanabe, F Wei, R Dubner, GT Huang and K Ren. (2011). Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain. Stem Cells 29:1294-1303.
59. Henschler R, E Deak and E Seifried. (2008). Homing of mesenchymal stem cells. Transfus Med Hemother 35:306-312.
60. Calvo M, JM Dawes and DL Bennett. (2012). The role of the immune system in the generation of neuropathic pain. Lancet Neurol 11:629-642.
61. Sacerdote P, S Franchi, AE Trovato, AE Valsecchi, AE Panerai and M Colleoni. (2008). Transient early expression of TNF-alpha in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy. Neurosci Lett 436:210-213.
62. Austin PJ and G Moalem-Taylor. (2010). The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol 229:26-50.
63. Mao F, WR Xu, H Qian, W Zhu, YM Yan, QX Shao and HX Xu. (2010). Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis. Inflamm Res 59:219-225.
64. Caplan AI and JE Dennis. (2006). Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076-1084.
65. Horwitz EM and WR Prather. (2009). Cytokines as the major mechanism of mesenchymal stem cell clinical activity: Expanding the spectrum of cell therapy. Isr Med Assoc J 11:209-211.
66. Kim H, JS Park, YJ Choi, MO Kim, YH Huh, SW Kim, JW Han, J Lee, S Kim, et al. (2009). Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy. Stem Cells 27:1686-1696.
67. Ranganath SH, O Levy, MS Inamdar and JM Karp. (2012). Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. In: Cell Stem Cell. A 2012 Elsevier Inc, United States. pp 244-258.
68. Anderson KJ, D Dam, S Lee and CW Cotman. (1988). Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature 332:360-361.
69. Nakae M, H Kamiya, K Naruse, N Horio, Y Ito, R Mizubayashi, Y Hamada, E Nakashima, N Akiyama, et al. (2006). Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes 55:1470-1477.